Gemtuzumab Ozogamicin Followed by Unrelated Cord Blood Transplantation With Reduced-intensity Conditioning for a Child With Refractory Acute Promyelocytic Leukemia

被引：2

作者：

Yamada, Yuji ^{[1
]}

Osumi, Tomoo ^{[1
]}

Kato, Motohiro ^{[1
]}

Shioda, Yoko ^{[1
]}

Kiyotani, Chikako ^{[1
]}

Terashima, Keita ^{[1
]}

Hayakawa, Akira ^{[2
,3
]}

Iijima-Yamashita, Yuka ^{[4
]}

Horibe, Keizo ^{[4
]}

Matsumoto, Kimikazu ^{[1
]}

Tomizawa, Daisuke ^{[1
]}

机构：

[1] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Tokyo, Japan

[2] Kobe Univ, Dept Pediat, Kobe, Hyogo, Japan

[3] Yodogawa Christians Hosp, Dept Palliat Med, Osaka, Japan

[4] Natl Hosp Org, Clin Res Ctr, Nagoya Med Ctr, Nagoya, Aichi, Japan

来源：

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 2022年 / 44卷 / 04期

关键词：

acute promyelocytic leukemia; relapsed; refractory; arsenic trioxide; all-trans retinoic acid; gemtuzumab ozogamicin; ACUTE MYELOID-LEUKEMIA; EVENT-FREE SURVIVAL; ARSENIC TRIOXIDE; ADOLESCENTS; EFFICACY; MYLOTARG; RELAPSE; 1ST; APL;

D O I：

10.1097/MPH.0000000000002404

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

There is no established treatment for patients with acute promyelocytic leukemia (APL) refractory to targeted therapies with all-trans retinoic acid (ATRA) and/or arsenic trioxide (ATO). We report here a case of an 8-month-old girl with APL who failed standard ATRA-combined chemotherapy. Although molecular remission was achieved after introducing ATRA/ATO combination therapy, molecular relapse occurred during the ATO consolidation courses. Subsequent molecular remission was rapidly achieved after administering 2 doses of gemtuzumab ozogamicin. She was successfully treated with unrelated cord blood transplantation using reduced-intensity conditioning. Gemtuzumab ozogamicin might be a preferable choice for patients with APL refractory to standard therapy.

引用

页码：178 / 180

页数：3

共 50 条

[31] Myeloablative Unrelated Cord Blood Transplantation in Adolescents and Young Adults with Acute Leukemia
Hayashi, Hiromi
Volt, Fernanda
Sanz, Jaime
Petersen, Eefke
Dhedin, Nathalie
Hough, Rachael
Milpied, Noel
Angelucci, Emanuele
Yakoub-Agha, Ibrahim
Michallet, Mauricette
Michel, Gerard
Aljurf, Mahmoud
Kenzey, Chantal
Rocha, Vanderson
Dalle, Jean-Hugues
Bader, Peter
Ruggeri, Annalisa
Gluckman, Eliane
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (12) : 2438 - 2446
[32] Fludarabine with cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with poor-risk chronic lymphocytic leukemia
Krejci, Marta
Doubek, Michael
Brychtova, Yvona
Stehlikova, Olga
Chovancova, Jana
Tichy, Boris
Francova, Hana Skuhrova
Navratil, Milan
Tomiska, Miroslav
Horky, Ondrej
Pospisilova, Sarka
Mayer, Jiri
ANNALS OF HEMATOLOGY, 2013, 92 (02) : 249 - 254
[33] Yttrium-90-labeled anti-CD45 antibody followed by a reduced-intensity hematopoietic cell transplantation for patients with relapsed/refractory leukemia or myelodysplasia
Phuong Vo
Gooley, Ted
Rajendran, Joseph G.
Fisher, Darrell R.
Orozco, Johnnie J.
Green, Damian J.
Gopal, Ajay K.
Haaf, Robyn
Nartea, Margaret
Storb, Rainer
Appelbaum, Frederick R.
Press, Oliver W.
Pagel, John M.
Sandmaier, Brenda M.
HAEMATOLOGICA, 2020, 105 (06) : 1731 - 1737
[34] Umbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplantation Outcomes
Eapen, Mary
Kurtzberg, Joanne
Zhang, Mei-Jie
Hattersely, Gareth
Fei, Mingwei
Mendizabal, Adam
Chan, Ka Wah
De Oliveira, Satiro
Schultz, Kirk R.
Wall, Donna
Horowitz, Mary M.
Wagner, John E.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (10) : 1714 - 1721
[35] Reduced-intensity cord blood transplantation without prior remission induction therapy induces durable remission in adult patients with relapsed acute leukemia after the first allogeneic transplantation
Ueki, Toshimitsu
Sumi, Masahiko
Sato, Keijiro
Shimizu, Ikuo
Akahane, Daigo
Ueno, Mayumi
Ichikawa, Naoaki
Nakao, Shinji
Kobayashi, Hikaru
EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 86 (03) : 268 - 271
[36] Reduced-Intensity Chemotherapy Plus Inotuzumab Ozogamicin, With or Without Sequential Blinatumomab, is Highly Effective as First Salvage Treatment in Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
Short, Nicholas
Jabbour, Elias
Sasaki, Koji
Ravandi, Farhad
Huang, Xuelin
Kebriaei, Partow
Jain, Nitin
Garcia-Manero, Guillermo
Kadia, Tapan
Konopleva, Marina
Jacob, Jovitta
Garris, Rebecca
Cortes, Jorge
O'Brien, Susan
Kantarjian, Hagop
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S186 - S187
[37] HLA-haploidentical peripheral blood stem cell transplantation following reduced-intensity conditioning with very low-dose antithymocyte globulin for relapsed/refractory acute leukemia in pediatric patients: a single-institution retrospective analysis
Higuchi, Kohei
Sawada, Akihisa
Kondo, Osamu
Okada, Yosuke
Tsujimoto, Hiroshi
Ioi, Aya
Mayumi, Azusa
Shimizu, Mariko
Sato, Maho
Goto, Kimitoshi
Inoue, Shota
Yasui, Masahiro
Inoue, Masami
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (03) : 406 - 413
[38] Comparison of Myeloablative Versus Reduced-Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: A Cohort Study
Ciftciler, Rafiye
Goker, Hakan
Demiroglu, Haluk
Aladag, Elifcan
Aksu, Salih
Haznedaroglu, Ibrahim Celalettin
Sayinalp, Nilgun
Ozcebe, Osman
Tekin, Fatma
Buyukasik, Yahya
TURKISH JOURNAL OF HEMATOLOGY, 2019, 36 (02) : 88 - 96
[39] Gemcitabine, Fludarabine; and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
Anderlini, Paolo
Saliba, Rima M.
Ledesma, Celina
Plair, Tamera
Alousi, Amin M.
Hosing, Chitra M.
Khouri, Issa F.
Nieto, Yago
Popat, Uday R.
Shpall, Elizabeth J.
Fanale, Michelle A.
Hagemeister, Frederick B.
Oki, Yasuhiro
Neelapu, Saatva
Romaguera, Jorge E.
Younes, Anas
Champlin, Richard E.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (07) : 1333 - 1337
[40] Successful treatment with low-dose gemtuzumab ozogamicin in combination chemotherapy followed by stem cell transplantation for children with refractory acute myeloid leukaemia
Yoshida, Nao
Sakaguchi, Hirotoshi
Matsumoto, Kimikazu
Kato, Koji
BRITISH JOURNAL OF HAEMATOLOGY, 2012, 158 (05) : 666 - 668

← 1 2 3 4 5 →